South & Central America Sepsis Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology [Molecular Diagnostics (Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, and Microarrays), Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, and Microbiology], Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User (Hospitals, Pathology and Reference Laboratories, and Others)

No. of Pages: 183    |    Report Code: BMIRE00028086    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South & Central America Sepsis Diagnostics Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. South & Central America Sepsis Diagnostics Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. South & Central America Sepsis Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 High sepsis mortality rates
  • 5.1.2 Need for rapid diagnosis
5.2 Market Opportunities
  • 5.2.1 Development of POC diagnostics
  • 5.2.2 Use of biomarkers
5.3 Future Trends
  • 5.3.1 Demand in critical care settings
  • 5.3.2 Government initiatives for better diagnostics
5.4 Impact of Drivers and Restraints

6. South & Central America Sepsis Diagnostics Market Regional Analysis

6.1 South & Central America Sepsis Diagnostics Market Overview
6.2 South & Central America Sepsis Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 South & Central America Sepsis Diagnostics Market Forecast Analysis

7. South & Central America Sepsis Diagnostics Market Analysis – by Product

7.1 Instruments
  • 7.1.1 Overview
  • 7.1.2 Instruments: South & Central America Sepsis Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Reagents and Assays
  • 7.2.1 Overview
  • 7.2.2 Reagents and Assays: South & Central America Sepsis Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Blood Culture Media
  • 7.3.1 Overview
  • 7.3.2 Blood Culture Media: South & Central America Sepsis Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Software
  • 7.4.1 Overview
  • 7.4.2 Software: South & Central America Sepsis Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. South & Central America Sepsis Diagnostics Market Analysis – by Technology

8.1 Molecular Diagnostics
  • 8.1.1 Overview
  • 8.1.2 Molecular Diagnostics: South & Central America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Flow Cytometry
  • 8.2.1 Overview
  • 8.2.2 Flow Cytometry: South & Central America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Microfluidics
  • 8.3.1 Overview
  • 8.3.2 Microfluidics: South & Central America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Immunoassay
  • 8.4.1 Overview
  • 8.4.2 Immunoassay: South & Central America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Biomarkers
  • 8.5.1 Overview
  • 8.5.2 Biomarkers: South & Central America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Microbiology
  • 8.6.1 Overview
  • 8.6.2 Microbiology: South & Central America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Sepsis Diagnostics Market Analysis – by Method

9.1 Automated Diagnostics and Conventional Diagnostics
  • 9.1.1 Overview
  • 9.1.2 Microbiology: South & Central America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. South & Central America Sepsis Diagnostics Market – South and Central America Analysis

10.1 South and Central America
  • 10.1.1 South & Central America Sepsis Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 South & Central America Sepsis Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 Brazil: South & Central America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 Brazil: South & Central America Sepsis Diagnostics Market Breakdown, by Product
    • 10.1.1.1.2 Brazil: South & Central America Sepsis Diagnostics Market Breakdown, by Technology
    • 10.1.1.1.3 Brazil: South & Central America Sepsis Diagnostics Market Breakdown, by Method
  • 10.1.1.2 Argentina: South & Central America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Argentina: South & Central America Sepsis Diagnostics Market Breakdown, by Product
    • 10.1.1.2.2 Argentina: South & Central America Sepsis Diagnostics Market Breakdown, by Technology
    • 10.1.1.2.3 Argentina: South & Central America Sepsis Diagnostics Market Breakdown, by Method
  • 10.1.1.3 Rest of South and Central America : South & Central America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Rest of South and Central America : South & Central America Sepsis Diagnostics Market Breakdown, by Product
    • 10.1.1.3.2 Rest of South and Central America : South & Central America Sepsis Diagnostics Market Breakdown, by Technology
    • 10.1.1.3.3 Rest of South and Central America : South & Central America Sepsis Diagnostics Market Breakdown, by Method

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. South & Central America Sepsis Diagnostics Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 BD
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 bioMerieux SA
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Danaher (Beckman Coulter)
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 F. HOFFMANN-LA ROCHE LTD.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 THERMO FISHER SCIENTIFIC INC.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - South & Central America Sepsis Diagnostics Market

  1. Abbott
  2. BD
  3. bioMerieux SA
  4. Danaher (Beckman Coulter)
  5. F. HOFFMANN-LA ROCHE LTD.
  6. THERMO FISHER SCIENTIFIC INC.
south-and-central-america-sepsis-diagnostics-market